Diabetic macular edema: it is more than just VEGF

Diabetic macular edema is a serious visual complication of diabetic retinopathy. This article reviews the history of previous and current therapies, including laser therapy, anti-vascular endothelial growth factor agents, and corticosteroids, that have been used to treat this condition. In addition,...

Descripción completa

Detalles Bibliográficos
Autores principales: Singer, Michael A., Kermany, Daniel S., Waters, Jana, Jansen, Michael E., Tyler, Lyndon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000Research 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4890310/
https://www.ncbi.nlm.nih.gov/pubmed/27303642
http://dx.doi.org/10.12688/f1000research.8265.1
_version_ 1782435100094365696
author Singer, Michael A.
Kermany, Daniel S.
Waters, Jana
Jansen, Michael E.
Tyler, Lyndon
author_facet Singer, Michael A.
Kermany, Daniel S.
Waters, Jana
Jansen, Michael E.
Tyler, Lyndon
author_sort Singer, Michael A.
collection PubMed
description Diabetic macular edema is a serious visual complication of diabetic retinopathy. This article reviews the history of previous and current therapies, including laser therapy, anti-vascular endothelial growth factor agents, and corticosteroids, that have been used to treat this condition. In addition, it proposes new ways to use them in combination in order to decrease treatment burden and potentially address other causes besides vascular endothelial growth factor for diabetic macular edema.
format Online
Article
Text
id pubmed-4890310
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher F1000Research
record_format MEDLINE/PubMed
spelling pubmed-48903102016-06-13 Diabetic macular edema: it is more than just VEGF Singer, Michael A. Kermany, Daniel S. Waters, Jana Jansen, Michael E. Tyler, Lyndon F1000Res Review Diabetic macular edema is a serious visual complication of diabetic retinopathy. This article reviews the history of previous and current therapies, including laser therapy, anti-vascular endothelial growth factor agents, and corticosteroids, that have been used to treat this condition. In addition, it proposes new ways to use them in combination in order to decrease treatment burden and potentially address other causes besides vascular endothelial growth factor for diabetic macular edema. F1000Research 2016-05-27 /pmc/articles/PMC4890310/ /pubmed/27303642 http://dx.doi.org/10.12688/f1000research.8265.1 Text en Copyright: © 2016 Singer MA et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review
Singer, Michael A.
Kermany, Daniel S.
Waters, Jana
Jansen, Michael E.
Tyler, Lyndon
Diabetic macular edema: it is more than just VEGF
title Diabetic macular edema: it is more than just VEGF
title_full Diabetic macular edema: it is more than just VEGF
title_fullStr Diabetic macular edema: it is more than just VEGF
title_full_unstemmed Diabetic macular edema: it is more than just VEGF
title_short Diabetic macular edema: it is more than just VEGF
title_sort diabetic macular edema: it is more than just vegf
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4890310/
https://www.ncbi.nlm.nih.gov/pubmed/27303642
http://dx.doi.org/10.12688/f1000research.8265.1
work_keys_str_mv AT singermichaela diabeticmacularedemaitismorethanjustvegf
AT kermanydaniels diabeticmacularedemaitismorethanjustvegf
AT watersjana diabeticmacularedemaitismorethanjustvegf
AT jansenmichaele diabeticmacularedemaitismorethanjustvegf
AT tylerlyndon diabeticmacularedemaitismorethanjustvegf

Ejemplares similares